NO20051715L - HCV assay - Google Patents

HCV assay

Info

Publication number
NO20051715L
NO20051715L NO20051715A NO20051715A NO20051715L NO 20051715 L NO20051715 L NO 20051715L NO 20051715 A NO20051715 A NO 20051715A NO 20051715 A NO20051715 A NO 20051715A NO 20051715 L NO20051715 L NO 20051715L
Authority
NO
Norway
Prior art keywords
antigen
hcv
assay
polyprotein
hcv assay
Prior art date
Application number
NO20051715A
Other languages
English (en)
Other versions
NO337695B1 (no
Inventor
David Y Chien
Phillip Arcangel
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of NO20051715L publication Critical patent/NO20051715L/no
Publication of NO337695B1 publication Critical patent/NO337695B1/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

2005 -05- 2 3 Det tilveiebringes en HCV antigen/antistoff/antigen analyse. Analysen benytter et isolert, første antigen fra et område av HCV polyprotein, og et HCV multippel epitop fusjonsantigen som inkluderer en epitop fra det samme området av polyproteinet som det første antigen. Både det første antigen og det multiple epitop fusjonsantigen binder antistoffer som er tilstede i en HCV-infisert prøve.
NO20051715A 2002-09-09 2005-04-06 Antigen-antistoff-antigen sandwich analyse metode for detektering av hepatitt C virus (HCV) infeksjon i en biologisk prøve samt anvendelse derav NO337695B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40951502P 2002-09-09 2002-09-09
PCT/US2003/028071 WO2004021871A2 (en) 2002-09-09 2003-09-08 Hcv assay

Publications (2)

Publication Number Publication Date
NO20051715L true NO20051715L (no) 2005-05-23
NO337695B1 NO337695B1 (no) 2016-06-06

Family

ID=31978759

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051715A NO337695B1 (no) 2002-09-09 2005-04-06 Antigen-antistoff-antigen sandwich analyse metode for detektering av hepatitt C virus (HCV) infeksjon i en biologisk prøve samt anvendelse derav

Country Status (15)

Country Link
US (1) US7166426B2 (no)
EP (1) EP1546414B1 (no)
JP (2) JP4585314B2 (no)
CN (1) CN1694971B (no)
AT (1) ATE410693T1 (no)
AU (1) AU2003273296B2 (no)
BR (1) BR0314166B8 (no)
CA (1) CA2498228C (no)
DE (1) DE60324003D1 (no)
ES (1) ES2312806T3 (no)
MX (1) MXPA05002641A (no)
NO (1) NO337695B1 (no)
NZ (1) NZ538711A (no)
PL (1) PL209710B1 (no)
WO (1) WO2004021871A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE527545T1 (de) * 2004-08-27 2011-10-15 Novartis Vaccines & Diagnostic Hcv-antigene zur mehrfachen epitopfusion mit modifizierten proteolytischen spaltungsorten und verwendungen davon
AU2005295317B2 (en) 2004-10-18 2011-10-13 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
US20080220448A1 (en) * 2006-09-01 2008-09-11 Blincko Stuart J Antigenic protein conjugates and process for preparing same
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
US8728489B2 (en) 2008-09-19 2014-05-20 Globeimmune, Inc. Immunotherapy for chronic hepatitis C virus infection
WO2011152793A1 (en) * 2010-06-02 2011-12-08 Mp Biomedicals Asia Pacific Pte Ltd Rapid multi-line hepatitis c virus assay
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN104697988B (zh) * 2015-02-10 2017-10-03 深圳市新产业生物医学工程股份有限公司 检测丙型肝炎病毒抗体的试剂盒及其检测方法和应用
CN111999496A (zh) * 2020-08-20 2020-11-27 必欧瀚生物技术（合肥）有限公司 一种SARS-CoV-2抗原抗体联合检测的试剂盒及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074422C (zh) 1987-11-18 2001-11-07 希龙股份有限公司 制备含有hcv表位的分离多肽的方法
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
JP2656995B2 (ja) 1989-03-17 1997-09-24 カイロン コーポレイション Ｎａｎｂｖの診断用薬
CA2032381C (en) * 1989-12-18 2006-02-21 Peter E. Highfield Viral agent
HU217025B (hu) 1990-04-04 1999-11-29 Chiron Corp. Hepatitis C vírus-(HCV) antigénkészítmények az anti-HCV-antitestek kimutatására immunoassay-kben
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
ES2188583T3 (es) 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
EP0935662B1 (en) 1996-05-24 2005-11-30 Chiron Corporation Multiple epitope fusion protein
US6514731B1 (en) 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
DE60129598T2 (de) * 2000-06-15 2008-04-17 Novartis Vaccines and Diagnostics, Inc., Emeryville Immunoassays für anti-hcv-antikörper

Also Published As

Publication number Publication date
EP1546414A2 (en) 2005-06-29
EP1546414B1 (en) 2008-10-08
AU2003273296A1 (en) 2004-03-29
EP1546414A4 (en) 2006-03-08
MXPA05002641A (es) 2005-05-05
NO337695B1 (no) 2016-06-06
WO2004021871A2 (en) 2004-03-18
CA2498228A1 (en) 2004-03-18
CN1694971A (zh) 2005-11-09
PL209710B1 (pl) 2011-10-31
WO2004021871A3 (en) 2005-02-24
US20040142321A1 (en) 2004-07-22
DE60324003D1 (en) 2008-11-20
ES2312806T3 (es) 2009-03-01
BR0314166B8 (pt) 2021-07-27
JP4585314B2 (ja) 2010-11-24
NZ538711A (en) 2007-01-26
PL375600A1 (en) 2005-12-12
JP2005538355A (ja) 2005-12-15
US7166426B2 (en) 2007-01-23
ATE410693T1 (de) 2008-10-15
AU2003273296B2 (en) 2009-11-26
BR0314166A (pt) 2005-07-19
CN1694971B (zh) 2010-05-26
BRPI0314166B1 (pt) 2016-06-14
CA2498228C (en) 2011-03-22
JP2009258128A (ja) 2009-11-05

Similar Documents

Publication Publication Date Title
NO20051715L (no) HCV assay
MXPA02012424A (es) Ensayo de combinacion de antigenos/anticuerpos para el virus de hepatitis c.
NO20004413D0 (no) HIV peptider, antigener, vaksine, blandinger, immunoassay, kit og en fremgangmÕte for pÕvisning av antistoffer som blir infusert av HIV
DE60141844D1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
DK1881064T3 (da) HCV-anti-kerne monoklonalt antistof
NO950006D0 (no) Immunoanalyse for anti-HCV antistoffer som anvender antigener med konformasjonsepitoper
DE69932812D1 (de) Epitope in der viralen hüllproteine und spezifische antikörper gegen diese epitope: verwendung für die detektion von hcv viralantigene im empfängergewebe
ATE542140T1 (de) Nichtstrukturelle hcv-proteinmutanten und verwendungsmöglichkeiten dafür
DK1295126T3 (da) Immunoanalysesystemer til påvisning af hepatitis C-virusantigen
DE69227776D1 (de) Monoklonale antikörper gegen mutmassliche hepatitis c-virus ns5-proteine und ihre anwendungsmethoden
EP1829891A3 (en) Immunoassays for Anti-HCV Antibodies
BR0204612C1 (pt) anticorpos monoclonais antinúcleo de hcv

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: BRYN AARFLOT AS, POSTBOKS 449 SENTRUM, 0104 OSLO

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: GRIFOLS WORLDWIDE OPERATIONS LIMITED, IE

MM1K Lapsed by not paying the annual fees